| Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey S Sevim, O Dogu, H Çamdeviren, R Bugdayci, T Sasmaz, H Kaleagasi, ... Neurology 61 (11), 1562-1569, 2003 | 335 | 2003 |
| Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey O Dogu, S Sevim, H Camdeviren, T Sasmaz, R Bugdayci, M Aral, ... Neurology 61 (12), 1804-1806, 2003 | 312 | 2003 |
| Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey S Sevim, O Dogu, H Kaleagasi, M Aral, O Metin, H Çamdeviren Journal of Neurology, Neurosurgery & Psychiatry 75 (2), 226-230, 2004 | 266 | 2004 |
| Ultrasound-guided versus ‘blind’intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease O Dogu, D Apaydin, S Sevim, DU Talas, M Aral Clinical neurology and neurosurgery 106 (2), 93-96, 2004 | 186 | 2004 |
| Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease H Unal Gulsuner, S Gulsuner, FN Mercan, OE Onat, T Walsh, H Shahin, ... Proceedings of the National Academy of Sciences 111 (51), 18285-18290, 2014 | 160 | 2014 |
| Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome S Sevim, O Dogu, H Çamdeviren, H Kaleagasi, M Aral, E Arslan, A Milcan Neurological Sciences 25, 48-52, 2004 | 127 | 2004 |
| Does age of onset in essential tremor have a bimodal distribution? Data from a tertiary referral setting and a population-based study ED Louis, O Dogu Neuroepidemiology 29 (3-4), 208-212, 2008 | 108 | 2008 |
| Clinical characteristics of essential tremor in Mersin, Turkey: A population–based door–to–door study O Dogu, ED Louis, S Sevim, H Kaleagasi, M Aral Journal of neurology 252, 570-574, 2005 | 103 | 2005 |
| SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia C Paisan-Ruiz, O Dogu, A Yilmaz, H Houlden, A Singleton Neurology 70 (16_part_2), 1384-1389, 2008 | 87 | 2008 |
| Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial M Ünal, S Sevim, O Doğu, Y Vayisoğlu, A Kanik Acta oto-laryngologica 123 (9), 1060-1063, 2003 | 84 | 2003 |
| Botulinum toxin-A therapy for palmar and plantar hyperhidrosis S Sevim, O Dogu, H Kaleagasi Acta neurologica belgica 102 (4), 167-170, 2002 | 81 | 2002 |
| The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis C Özcan, Y Vayisoglu, O Doğu, K Görür American journal of otolaryngology 27 (5), 314-318, 2006 | 70 | 2006 |
| Serum lipids in epileptic children treated with carbamazepine and valproate DT Sözüer, D Atakli, O Dogu, S Baybas, B Arpaci European journal of pediatrics 156, 565-567, 1997 | 64 | 1997 |
| Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor AQ Rana, A Kabir, O Dogu, A Patel, S Khondker European neurology 68 (5), 318-321, 2012 | 52 | 2012 |
| Elevated blood lead concentrations in essential tremor: a case–control study in Mersin, Turkey O Dogu, ED Louis, L Tamer, O Unal, A Yilmaz, H Kaleagasi Environmental health perspectives 115 (11), 1564-1568, 2007 | 52 | 2007 |
| Abnormal MRI in a patient with ‘headache with neurological deficits and CSF lymphocytosis (HaNDL)’ A Yilmaz, H Kaleagasi, O Dogu, E Kara, A Ozge Cephalalgia 30 (5), 615-619, 2010 | 51 | 2010 |
| Isolated head tremor: part of the clinical spectrum of essential tremor? Data from population‐based and clinic‐based case samples ED Louis, O Dogu Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009 | 47 | 2009 |
| Turkish standardization of movement disorders society unified Parkinson's disease rating scale and unified dyskinesia rating scale MC Akbostanci, E Bayram, V Yilmaz, S Rzayev, S Özkan, AB Tokcaer, ... Movement disorders clinical practice 5 (1), 54-59, 2018 | 44 | 2018 |
| Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions IE Eryilmaz, G Cecener, S Erer, U Egeli, B Tunca, M Zarifoglu, B Elibol, ... Neurological research 39 (11), 965-972, 2017 | 43 | 2017 |
| The p. Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN S Olgiati, O Doğu, Z Tufekcioglu, Y Diler, E Saka, M Gultekin, H Kaleagasi, ... Parkinsonism & related disorders 39, 64-70, 2017 | 40 | 2017 |
